- Report
- August 2025
- 372 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 278 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 371 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 272 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 485 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 182 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 279 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 284 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 273 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 282 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 175 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 282 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 485 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 377 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 179 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 475 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 282 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 276 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 149 Pages
Global
From €5208EUR$5,850USD£4,501GBP
- Report
- August 2025
- 177 Pages
Global
From €5208EUR$5,850USD£4,501GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more